Literature DB >> 34260391

Reply to Zhuang et al.: Potential side effects of positive allosteric modulators of the mu-opioid receptor.

John R Traynor1,2.   

Abstract

Entities:  

Year:  2021        PMID： 34260391      PMCID： PMC8285960          DOI： 10.1073/pnas.2108493118

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  8 in total

1.  Effects of the potent analgesic enkephalin-catabolizing enzyme inhibitors RB101 and kelatorphan on respiration.

Authors:  E Boudinot; M Morin-Surun; A S Foutz; M Fournié-Zaluski; B P Roques; M Denavit-Saubié
Journal:  Pain       Date:  2001-02-01       Impact factor: 6.961

2.  Ascent of the kappa-opioid receptor in psychopharmacology.

Authors:  William A Carlezon; Klaus A Miczek
Journal:  Psychopharmacology (Berl)       Date:  2010-04-17       Impact factor: 4.530

3.  Unlike morphine the endogenous enkephalins protected by RB101 are unable to establish a conditioned place preference in mice.

Authors:  F Noble; M C Fournié-Zaluski; B P Roques
Journal:  Eur J Pharmacol       Date:  1993-01-12       Impact factor: 4.432

4.  Pharmacological Properties of δ-Opioid Receptor-Mediated Behaviors: Agonist Efficacy and Receptor Reserve.

Authors:  Isaac J Dripps; Ruizhuo Chen; Amanda M Shafer; Kathryn E Livingston; Alexander Disney; Stephen M Husbands; John R Traynor; Kenner C Rice; Emily M Jutkiewicz
Journal:  J Pharmacol Exp Ther       Date:  2020-05-28       Impact factor: 4.030

5.  Use of preproenkephalin knockout mice and selective inhibitors of enkephalinases to investigate the role of enkephalins in various behaviours.

Authors:  Florence Noble; Nadia Benturquia; Andras Bilkei-Gorzo; Andreas Zimmer; Bernard P Roques
Journal:  Psychopharmacology (Berl)       Date:  2007-10-01       Impact factor: 4.530

6.  Do positive allosteric modulators (PAMs) of the MOR exert antinociception with reduced side effects under pathological conditions?

Authors:  Tao Zhuang; Yurong Ma; Guisen Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-13       Impact factor: 11.205

7.  Positive allosteric modulation of the mu-opioid receptor produces analgesia with reduced side effects.

Authors:  Ram Kandasamy; Todd M Hillhouse; Kathryn E Livingston; Kelsey E Kochan; Claire Meurice; Shainnel O Eans; Ming-Hua Li; Andrew D White; Bernard P Roques; Jay P McLaughlin; Susan L Ingram; Neil T Burford; Andrew Alt; John R Traynor
Journal:  Proc Natl Acad Sci U S A       Date:  2021-04-20       Impact factor: 11.205

8.  Measuring ligand efficacy at the mu-opioid receptor using a conformational biosensor.

Authors:  Kathryn E Livingston; Jacob P Mahoney; Aashish Manglik; Roger K Sunahara; John R Traynor
Journal:  Elife       Date:  2018-06-22       Impact factor: 8.140
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.